2m 2m 2m 2m 2m 2m 2m
CYTEK BIOSCI (CTKB)
NASDAQ
$4.07$0.00 (0.00%)
Price as of Jun 23, 2026 7:26 PM EDT- $498.5MMarket Cap
- 26.01%1-Year Change
- Medical DevicesIndustry
CYTEK BIOSCI (CTKB)
$4.07$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 144.2M -28.05% | 200.5M +3.85% | 193.0M +17.67% | 164.0M +28.20% | |
Cost of Revenue | 69.8M -21.86% | 89.3M +6.89% | 83.6M +32.55% | 63.1M +29.21% | |
Gross Profit | 104.5M -5.98% | 111.1M +1.54% | 109.4M +8.37% | 101.0M +27.58% | |
Sales and Marketing Expense | 49.4M +0.66% | 49.1M -0.07% | 49.1M +47.90% | 33.2M +34.48% | |
Research and Development Expense | -36.5M -7.45% | -39.4M -10.76% | -44.2M +26.66% | -34.9M +42.62% | |
Depreciation and Amortization Expense | 7.6M +5.09% | 7.2M +19.25% | 6.0M +142.70% | 2.5M +100.64% | |
Total Operating Expenses | 144.8M +10.04% | 131.6M -4.11% | 137.3M +33.56% | 102.8M +46.85% | |
Operating Profit | -40.4M +96.77% | -20.5M -26.30% | -27.8M +1,443.51% | -1.8M -119.70% | |
Interest Income | 2.2M -56.73% | 5.1M -20.15% | 6.4M +38.84% | 4.6M +9,326.53% | |
Interest Expense | N/A N/A | N/A N/A | -2.1M -19.51% | -2.6M +47.79% | |
Interest Income and Expense and Net | 2.2M -56.73% | 5.1M +17.94% | 4.3M +112.22% | 2.0M +220.92% | |
Total Nonoperating Income and Expense | 10.5M -28.87% | 14.8M +22.14% | 12.1M +296.08% | 3.1M +195.18% | |
Income before Taxes | -29.8M +423.53% | -5.7M -63.72% | -15.7M -1,346.75% | 1.3M -78.78% | |
Income Taxes | 36.7M +11,368.13% | 320,000 +108.99% | -3.6M +190.93% | -1.2M -142.05% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -66.5M +1,005.30% | -6.0M -50.44% | -12.1M -589.05% | 2.5M -17.94% | |
Net Income from Continuing Operations Applicable to Common | -66.5M +1,005.30% | -6.0M -50.44% | -12.1M -571.58% | 2.6M N/A | |
Basic EPS and Net Income | N/A N/A | N/A N/A | -0.09 -550.00% | 0.02 N/A | |
Diluted EPS and Net Income | N/A N/A | N/A N/A | -0.09 -550.00% | 0.02 N/A | |
Basic Weighted Average Shares | 127.7M -2.19% | 130.6M -3.45% | 135.3M +0.57% | 134.5M +75.28% | |
Diluted Weighted Average Shares | 127.7M -2.19% | 130.6M -3.45% | 135.3M -2.37% | 138.6M +69.93% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 90.9M -7.97% | 98.7M -40.99% | 167.3M -43.59% | 296.6M -18.65% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 90.9M -7.97% | 98.7M -40.99% | 167.3M -43.59% | 296.6M -18.65% | |
Total Current Assets | 392.0M -1.12% | 396.4M +1.12% | 392.1M -13.65% | 454.0M +5.16% | |
Accumulated Depreciation | 12.1M +39.25% | 8.7M +47.20% | 5.9M +87.40% | 3.2M +69.84% | |
Property and Plant and Equipment and Net | 18.0M +0.26% | 18.0M -2.41% | 18.4M +34.52% | 13.7M +133.84% | |
Total Long-Term Assets | 6.7M +40.87% | 4.8M +40.59% | 3.4M +14.47% | 3.0M +77.60% | |
Total Assets | 461.5M -7.60% | 499.5M +1.02% | 494.5M -4.82% | 519.5M +12.12% | |
Income Taxes Payable | 6.3M +76.54% | 3.6M +16.31% | 3.1M +83.56% | 1.7M -57.03% | |
Total Short-Term Debt | 12.0M -29.41% | 17.0M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 77.8M +14.99% | 67.7M +20.34% | 56.2M +14.65% | 49.0M +47.80% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 2.3M -2.41% | 2.4M -2.76% | 2.4M +53.18% | 1.6M +31.81% | |
Total Liabilities | 119.8M +15.46% | 103.8M +2.34% | 101.4M +7.95% | 93.9M +62.17% | |
Retained Earnings | -101.7M +189.04% | -35.2M +20.64% | -29.2M +71.33% | -17.0M -13.14% | |
Total Stockholders Equity | 341.7M -13.64% | 395.7M +0.68% | 393.1M -7.63% | 425.5M +4.97% | |
Total Shares Outstanding | 128.6M -0.51% | 129.2M -1.15% | 130.7M -3.44% | 135.4M +1.21% | |
Cash Flow | |||||
Cash from Operating Activities | -4.7M -118.46% | 25.4M +380.57% | 5.3M +143.18% | -12.2M -364.17% | |
Capital Expenditures | 4.1M +15.86% | 3.5M -24.16% | 4.6M -52.32% | 9.7M +123.37% | |
Cash from Investing Activities | 10.1M +112.19% | -83.0M -11.63% | -93.9M +67.94% | -55.9M +166.32% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -13.4M -15.11% | -15.8M -62.16% | -41.8M -858.43% | 5.5M -97.42% | |
Financials Ratio | |||||
Gross Margin | 51.60% -6.91% | 55.43% -2.23% | 56.69% -7.90% | 61.56% N/A | |
Operating Margin | -28.00% +173.47% | -10.24% -29.03% | -14.43% +1,211.72% | -1.10% N/A | |
Return on Assets | -13.85% +1,043.18% | -1.21% -49.45% | -2.40% -574.03% | 0.51% N/A | |
Return on Equity | -18.05% +1,082.20% | -1.53% -48.57% | -2.97% -596.40% | 0.60% N/A | |
Revenue Growth | -28.05% -827.80% | 3.85% -78.19% | 17.67% -37.36% | 28.20% N/A | |
Current Ratio | 5.04 -14.01% | 5.86 -15.97% | 6.97 -24.68% | 9.26 N/A | |
Cash Ratio | 1.17 -19.96% | 1.46 -50.97% | 2.98 -50.80% | 6.05 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow